Overview

The Efficacy and Safety of PAZ320 on PPG and Insulin Blood Levels in Type II Diabetic Patients

Status:
Withdrawn
Trial end date:
2013-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test the efficacy of PAZ320 in diabetic patients.
Phase:
Phase 2
Details
Lead Sponsor:
Boston Therapeutics
Treatments:
PAZ320